Clinical studies Compared with the considerable amount of pre-clinical and mechanistic research reported above, we identified few clinical studies of GLP-1RAs for substance-use disorders (Table 2): three for alcohol 111,112,113 , one for cannabis 114 , two for cocaine 115,116 and two for nicotine 117,118 , while no article about opiates or amphetamines was retrieved
It gives very good protection across the whole UVA range (310-400 nm that is both UVA1 and UVA2) with a peak protection at 360 nm
Kong Med J
Recent data show approximately 70% of GLP-1 prescriptions in the US are now written for weight loss rather than glucose control, yet individual response varies significantly based on genetic and metabolic factors
Patients must focus on nutrition, exercise, and overall wellness to achieve long-term success
The medication is self-administered as a subcutaneous injection in the stomach, thigh, or upper arm once a week on the same day every week